Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 107.00 105.00 109.00 107.00 107.00 107.00 682 00:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 13.0 -23.1 -8.4 - 232

Amryt Pharma Share Discussion Threads

Showing 5026 to 5041 of 5325 messages
Chat Pages: 213  212  211  210  209  208  207  206  205  204  203  202  Older
DateSubjectAuthorDiscuss
16/9/2019
16:05
Actually mdalos's target price of 133p before he sells is not a bad short term target based on the AMYT chart (not the long term AMYT chart shown in the header because ADVFN haven't taken a/c of the share consolidation). When it relisted AMYT went from the pre suspension price of 76p (allowing for consolidation) to close at 106p. An effective rise of 30p on the day. Chart theory says we could have a similar rise from the subsequent low of 103p. That would give a short term target of 133p. Will I follow mdalos's stated aim and sell at 133p? No, is the answer. Why? Because I agree with Mark Taub and Cathal Friel and believe, rightly, or wrongly, that this new AMYT/Aegerion combination is undervalued and will be significantly rerated when it lists on the Nasdaq sometime in Q4 2019. I agree, rightly, or wrongly, that Mark Taub & Cathal Friel are correct when they state that the new AMYT/Aegerion combination is significantly undervalued compared with it's prospective peer group on the Nasdaq based on the growth prospects of Aegerion's existing marketed drugs, Juxtapid/Lojuxta and Myalept, even without a contribution from AP101.
papillon
16/9/2019
15:04
Mdalos1 you are right. The CVR would be nice but if it doesn't happen so be it.
chica1
16/9/2019
12:33
What about free fall parachute jumping? Bog snorkelling? Feeding the Donkeys in a Sanctuary? The possibilities are endless!! I’m killing time on a train!
bazworth
16/9/2019
12:22
Papillon, I'm actually a fan the majority of the time but you need another hobby
tiananmen
16/9/2019
12:04
I posted that link on this bb last Thursday, dim2602. It was originally posted on the lse bb by Cadburyhill last Thursday. I've also mentioned Mark Taub's bullish opinion on both NVLN & AMYT more than once since then in my posts.
papillon
16/9/2019
11:30
I've added to my holding. I think there will be a material share price increase once AMRYT lists on Nasdaq. Although the link below is a buy recommendation for Novelion, which will hold around 8% of new Amryt shares after the deal, a lot of the information is relevant to Amryt shareholders too. Specifically, with the share price of new Amryt at £1.435 on Nasdaq listing this values the company at around $308m and enterprise value of around $458m. With 2018 sales of $137m this gives an EV/Sales ratio of 3.3. This compares very favourably with Amryts peer group listed here where the next lowest is 3.9 and the median of the group at 6. Amryt will hope that the Nasdaq listing goes well and there is a strong appetite for the shares, so I think they have deliberately factored in a discount to the listing price. If we assume that Amryt reaches the 3.9 ratio of the next lowest company in the peer group, that would give a share price of £1.70 Further, this is based on 2018 sales of $137m. The forecast for revenues in 2020 and 2021 are $200.7 and $314 respectively. If the EV/Sales ratio stays the same, this would imply a further increase in share price to £2.50 and £3.90 respectively. Ok, there are many of assumptions and estimates to get to these valuations and there could be a few hurdles along the way. But I like the risk/reward here and you currently get the CVR's worth up to £1.22 per share (but could be zero) in for free. As always DYOR https://seekingalpha.com/article/4290742-novelions-8_1-percent-stake-amryt-worth-1_50-share?dr=1
dlm2602
16/9/2019
11:26
So mdalos has sold all his shares then, bazworth? I didn't realise he had as many as 700+. I thought I was a small shareholder with my tiny 5k. LOL.
papillon
16/9/2019
09:49
See you’ve sold your 700+ shares mdalos1, well done!!
bazworth
16/9/2019
09:38
Good and spend it wisely. You should really try to be more positive,negatively is a silent killer .
chica1
16/9/2019
08:34
Don’t do that - it’s orrible!
bazworth
15/9/2019
23:05
Cathal Friel did say that, chica, in the link provided by Bermudashorts. Friel definitely says in that youtube video interview that AMYT will list on the Nasdaq in November. He may not be on the AMYT BoD anymore, but I've an idea he knows more than mdalos! LOL. If Mark Taub is correct in that AMYT will be significantly undervalued compared with it's peer group when it lists on the Nasdaq will we then see the AMYT share price significantly rerated, or will the rerating start before it lists on Nasdaq? Plenty to look forward to in Q4 2019.
papillon
15/9/2019
19:29
This is the Dog’s B’s of a BB! Better than watching the Soaps by a country mile!! Keep going folks, priceless
bazworth
15/9/2019
18:16
He did Chica
alphabravo321
15/9/2019
17:58
Didn't Cathal Friel just say this week that the plan is Nasdaq listing in November.
chica1
15/9/2019
14:32
"you are SO ANNOYING!" I agree with you, chica. mdalsos is "SO ANNOYING!" which is why I have him on filter. You should try filtering him. I promise not to peek at his posts again and hence will not respond to them in future. "I have read that the AIM stock exchange is the wild west and to stay a mile away but I was told when AMYT gets on the Nasdaq and if management do their job property American investors reward the company appropriately.Did'nt the CEO at some stage say he wanted to create another Shire Pharmaceuticals?". I agree with you chica!
papillon
15/9/2019
13:07
I dont know much about investing but I thought investing was for the long term.I've little or no clue what a CVR but if we get it great, if not so what. I have read that the AIM stock exchange is the wild west and to stay a mile away but I was told when AMYT gets on the Nasdaq and if management do their job property American investors reward the company appropriately.Did'nt the CEO at some stage say he wanted to create another Shire Pharmaceuticals? Both of you are SO ANNOYING!
chica1
Chat Pages: 213  212  211  210  209  208  207  206  205  204  203  202  Older
Your Recent History
LSE
AMYT
Amryt Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191210 11:12:31